GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,026,000 | +12.0% | 42,926 | -31.6% | 0.01% | -14.3% |
| Q4 2020 | $916,000 | +65.6% | 62,745 | +61.3% | 0.01% | 0.0% |
| Q3 2020 | $553,000 | -66.2% | 38,910 | -65.1% | 0.01% | -73.1% |
| Q2 2020 | $1,638,000 | +169.9% | 111,335 | -24.4% | 0.03% | +62.5% |
| Q1 2020 | $607,000 | -46.6% | 147,258 | -37.7% | 0.02% | +128.6% |
| Q4 2019 | $1,137,000 | -33.7% | 236,413 | -16.4% | 0.01% | -53.3% |
| Q3 2019 | $1,715,000 | +45.1% | 282,946 | +55.3% | 0.02% | +25.0% |
| Q2 2019 | $1,182,000 | +246.6% | 182,178 | +278.8% | 0.01% | +200.0% |
| Q1 2019 | $341,000 | +348.7% | 48,094 | +244.9% | 0.00% | +300.0% |
| Q1 2018 | $76,000 | +46.2% | 13,943 | +11.7% | 0.00% | 0.0% |
| Q4 2017 | $52,000 | -69.6% | 12,480 | -10.8% | 0.00% | -85.7% |
| Q4 2016 | $171,000 | +216.7% | 13,986 | +37.1% | 0.01% | +75.0% |
| Q1 2016 | $54,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 2,730,000 | $11,384,000 | 2.77% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,017,483 | $20,923,000 | 1.28% |
| Ghost Tree Capital, LLC | 500,000 | $2,085,000 | 0.49% |
| Bellevue Group AG | 773,677 | $3,226,000 | 0.34% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 180,000 | $750,000 | 0.20% |
| Penn Capital Management Company, LLC | 543,715 | $2,267,000 | 0.16% |
| HighTower Advisors, LLC | 2,355,942 | $9,826,000 | 0.08% |
| Granite Investment Partners, LLC | 215,760 | $900,000 | 0.06% |
| WRAPMANAGER INC | 39,547 | $165,000 | 0.05% |
| Alyeska Investment Group, L.P. | 1,563,881 | $6,521,000 | 0.05% |